Loureiro, Joana A.

The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019

Castelpietra, G., Knudsen, A. K. S., Agardh, E. E., Armocida, B., Beghi, M., Iburg, K. M., Logroscino, G., Ma, R., Starace, F., Steel, N., et al. (2022) · The Lancet Regional Health - Europe

Mental Health Treatment and AccessSuicide and Self-Harm Studies

Cited by 347

Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies

Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · International Journal of Molecular Sciences

Alzheimer's disease research and treatmentsMedicinal Plants and Neuroprotection

Cited by 240

Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment

Andrade, S., Ramalho, M. J., Pereira, M. D. C., & Loureiro, J. A. (2018) · Frontiers in Pharmacology

Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems

Cited by 173

Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds

Ramalho, M. J., Andrade, S., Loureiro, J. A., & do Carmo Pereira, M. (2020) · Drug Delivery and Translational Research

Alzheimer's disease research and treatmentsNanoparticle-Based Drug Delivery

Cited by 75

Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs

Nunes, D., Loureiro, J. A., & Pereira, M. C. (2022) · Pharmaceutics

Cholinesterase and Neurodegenerative DiseasesAdvanced Drug Delivery Systems

Cited by 68

Transferrin-functionalized liposomes loaded with vitamin VB12 for Alzheimer’s disease therapy

Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. C. (2022) · International Journal of Pharmaceutics

Nanoparticle-Based Drug DeliveryAlzheimer's disease research and treatments

Cited by 63